🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms

RecruitingNAAges 18 Years - anyFemaleUniversity of Illinois at Chicago
NCT07485036 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to learn about depression and alcohol use in postpartum mothers and whether an intervention based on contingency management and problem-solving therapy (CM-PST) can help reduce these symptoms. The main questions it seeks to answer are: 1. How do new mothers fare with depressive symptoms and alcohol use in the first 12 months after giving birth? 2. Will a CM-PST intervention reduce depressive symptoms and alcohol use frequency among new mothers? 3. Is a CM-PST intervention practical for new mothers? The researchers will recruit approximately 30 new mothers and randomly select half to attend a 6-week CM-PST intervention. They will compare those who received the intervention versus those who did not to see if there are any differences in their depressive symptoms and alcohol usage. Participants will: * Complete 4 remote intervention sessions over 6 weeks * Conduct at-hom

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Biologically female * Age ≥18 years * Within 12 months postpartum * Able to provide informed consent Exclusion Criteria: * Serious medical or psychiatric conditions requiring hospitalization * Lifetime DSM-5 diagnosis of schizophrenia, bipolar disorder, or any psychiatric disorder * Current use of psychoactive drugs, medication to treat problematic alcohol use, or depression * Participation in past 6 months in problematic alcohol use or substance use treatment * Unable to provide consent
💊

What it tests

  • Contingency Management & Problem Solving Therapy
  • Usual Care
📍

Where

1 site
University of Illinois Hospital and Health Sciences System, University of Illinois College of Medicine
Chicago, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy